InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Pankovcin Corinne, Chief Financial Officer. Director active across 1 company, notably Aditx Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €18k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 4 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Corinne Pankovcin is the Chief Financial Officer at Aditx Therapeutics, Inc. In this role, she oversees the company's financial operations, including budgeting and risk management. Her expertise is crucial for ensuring the company's financial health.